Introducing the MTIP EverHealth Fund:
Evergreen Private Equity for European Healthcare Technology

We are pleased to announce the launch of the MTIP EverHealth Fund, our new evergreen private equity strategy focused on European healthcare technology.

‍

Structured as a Luxembourg-domiciled European Long-Term Investment Fund (ELTIF), EverHealth provides investors with access to a dedicated portfolio at the intersection of healthcare and technology through an open-ended structure designed to offer greater flexibility in accessing private equity.

‍

The Fund builds on MTIP’s more than a decade of experience investing in healthcare technology and will invest across three main areas: direct investments in European healthcare technology companies, follow-on investments in selected MTIP portfolio companies, and selected secondary opportunities across healthcare and technology.

‍

Building on our healthcare technology expertise

Since 2014, we have focused on partnering with healthcare technology companies across Europe, combining deep sector expertise, trusted industry relationships, and a pan-European network with active portfolio support.

‍

Through majority and minority investments, MTIP provides flexible capital solutions tailored to the individual needs and growth ambitions of each company, working closely with founders and management teams to support expansion, operational performance, and scale.

‍

With an international team speaking ten European languages, MTIP is well positioned to support healthcare technology companies in expanding across European markets.

‍

Dr. Christoph Kausch, Managing Partner at MTIP, comments:

‍

“The launch of the MTIP EverHealth Fund marks an important next step for MTIP: it allows us to bring our specialist healthcare technology investment strategy into an evergreen format and provide investors with a flexible way to access private equity. At the same time, our investment approach remains unchanged: identifying attractive healthcare technology businesses across Europe and partnering with their management teams to support long-term growth.”

‍

Private equity in an evergreen format

EverHealth is structured as a semi-liquid, open-ended fund with no fixed end date. The Fund offers EUR and CHF share classes, fully funded shares without traditional capital calls, and quarterly subscription and redemption opportunities.*

‍

By combining new direct investments, opportunities from within the existing MTIP ecosystem and selected secondaries, we aim to build a diversified portfolio of European healthcare technology investments over time.

‍

The MTIP EverHealth Fund is now open for subscriptions.

‍

For further information about EverHealth, please contact our Investor Relations team at ir@mtip.ch.

‍

Important information: This press release is provided for information purposes only and does not constitute an offer, solicitation, recommendation or investment advice. It is directed exclusively at professional investors and eligible counterparties in accordance with applicable laws and regulations and is not intended for distribution to retail investors. Any investment decision should be made solely on the basis of the Fund’s official documentation. The prospectus and KID are available free of charge at https://www.mtip.ch/mtip-everhealth-fund#Key-Documents. MTIP EverHealth Fund SA, SICAV-OPC Part II, ELTIF (the“Fund”) is a Luxembourg-domiciled European Long-Term Investment Fund investing primarily in European healthcare technology companies and related opportunities. The Fund is designed for long-term investment in illiquid assets. Investments involve risk, including the possible loss of capital. The Fund’s underlying investments are long-term and illiquid in nature, and redemption opportunities are subject to the Fund’s terms and may be limited, deferred or suspended. Investors should only allocate a small proportion of their overall investment portfolio to the Fund. There can be no assurance that the Fund will achieve its investment objectives. Past performance is not indicative of future results. Investors should refer to the Fund documentation for complete information regarding the Fund, including its investment strategy, eligibility requirements, fees, risks and applicable minimum investment thresholds. The Fund is authorised by the Commission de Surveillance du Secteur Financier (CSSF) and managed by Hauck & Aufhäuser Fund Services S.A. as its alternative investment fund manager (AIFM) with fundcraft acting as the Fund’s central administrator.

‍

*Quarterly subscriptions and redemptions are subject to the terms of the Fund, including an initial three-year lockup, a three-month notice period, and applicable gates.

‍

About MTIP

MTIP is a Swiss-based specialist growth and buyout investor focused on European healthcare technology. We invest in AI-enabled and software-driven healthcare companies through majority and minority structures, partnering closely with founders and management teams to scale market-leading businesses. With deep sector expertise and an active ownership approach, we drive sustainable growth and long-term value creation for our portfolio companies and investors.

‍

For more information, visit www.mtip.ch/mtip-everhealth-fund.  

‍

Media Contact:
Anja-Vanessa Peter

Investor Relations & Communication Manager

anja.peter@mtip.ch

‍

‍

‍

‍